⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL845067 | 0.95 | G6PD (0.43) | — | |
| Hydrochloric Acid SCHEMBL845068 | 0.95 | G6PD (0.43) | — | |
| SCHEMBL113475 | 0.80 | — | — | |
| SCHEMBL69654 | 0.80 | — | — | |
| Methane SCHEMBL1703075 | 0.77 | SMN1; SMN2 (0.43) | — | |
| Bromide SCHEMBL29216576 | 0.77 | CES2 (0.39) | — | |
| Iodide SCHEMBL29216564 | 0.77 | CES2 (0.39) | — | |
| Hydrochloric Acid SCHEMBL7423355 | 0.77 | CES2 (0.39) | — | |
| Hydrochloric Acid SCHEMBL766671 | 0.77 | G6PD (0.54) | — | |
| Phenol SCHEMBL27889282 | 0.75 | CA14 (0.52) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 259 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113441135-B | Preparation method of 2-amino-3H-phenoxazin-3-one or derivative thereof | 兰州大学 | 2022-09-20 | — | — | CN | claimed |
| CN-113441135-A | Preparation method of 2-amino-3H-phenoxazin-3-one or derivative thereof | 兰州大学 | 2021-09-28 | — | — | CN | claimed |
| EP-0624567-A2 | Derivatives of 3-fluorophenol, process for their preparation and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1994-11-17 | — | — | EP | claimed |
| JP-7070007-A | — | — | None | — | — | JP | disclosed |
| EP-4709425-A1 | LINKER COMPOUNDS AND LIGAND-DRUG CONJUGATES, PREPARATION METHODS AND USES THEREOF | Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (CN) | 2026-03-18 | — | — | EP | disclosed |
| EP-4539840-A1 | KINASE MODULATORS AND METHODS OF USE THEREOF | Neuron23, Inc. (US) | 2025-04-23 | — | — | EP | disclosed |
| CN-119775261-A | Collagen 1 translation inhibitors and methods of use thereof | 艾尼莫生物科技公司 | 2025-04-08 | — | — | CN | disclosed |
| CN-119730846-A | Kinase modulators and methods of use thereof | 神经元23公司 | 2025-03-28 | — | — | CN | disclosed |
| CN-119241427-A | Method for comprehensively and efficiently synthesizing anticancer drug regorafenib | 董帅圻 | 2025-01-03 | — | — | CN | disclosed |
| CN-115427404-B | Collagen 1 translation inhibitors and methods of use thereof | 艾尼莫生物科技公司 | 2024-12-13 | — | — | CN | disclosed |
| WO-2024235105-A1 | LINKER COMPOUNDS AND LIGAND-DRUG CONJUGATES, PREPARATION METHODS AND USES THEREOF | BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD. (CN) | 2024-11-21 | — | — | WO | disclosed |
| US-5780483-A | IL-8 receptor antagonists | SMITHKLINE BEECHAM CORPORATION (US) | 1998-07-14 | — | — | US | disclosed |
| EP-0809492-A1 | IL-8 RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1997-12-03 | — | — | EP | disclosed |
| WO-1997029743-A1 | IL-8 RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1997-08-21 | — | — | WO | disclosed |
| WO-1996025157-A1 | IL-8 RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1996-08-22 | — | — | WO | disclosed |
| US-5410082-A | Process for preparing amines | CLARIANT GMBH (DE) | 1995-04-25 | — | — | US | disclosed |
| JP-H0770007-A | NOVEL DERIVATIVE OF 3-FLUOROPHENOL, ITS PRODUCTION AND USE | HOECHST AG | 1995-03-14 | — | — | JP | disclosed |
| EP-0628536-A2 | Process for the preparation of amines | HOECHST AKTIENGESELLSCHAFT (DE) | 1994-12-14 | — | — | EP | disclosed |
| EP-0624567-A2 | Derivatives of 3-fluorophenol, process for their preparation and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1994-11-17 | — | — | EP | disclosed |
| EP-0462800-A2 | Inhibitors of HIV reverse transcriptase | MERCK & CO. INC. (US) | 1991-12-27 | — | — | EP | disclosed |